Inventor · disambiguated record
Anita Wiebe
Also filed as: WIEBE ANITA
74 granted patents·19 pending applications·145 citations·filing 2015–2025
99Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH93
Top patents by PatentIndex Score
93 records- 0199US11123370B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 21, 2021·4 cites·20 claims
- 0299US11058726B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 13, 2021·4 cites·20 claims
- 0398US10842817B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 24, 2020·4 cites·20 claims
- 0498US10780125B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Sep 22, 2020·4 cites·20 claims
- 0596US11679147B2Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jun 20, 2023·2 cites·20 claims
- 0696US11672848B2Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jun 13, 2023·2 cites·20 claims
- 0796US11576956B2Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 14, 2023·2 cites·20 claims
- 0896US10526386B2Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Jan 7, 2020·7 cites·13 claims
- 0996US10513547B2Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Dec 24, 2019·6 cites·16 claims
- 1096US10442844B2Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Oct 15, 2019·6 cites·18 claims
- 1196US10435448B2Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Oct 8, 2019·6 cites·18 claims
- 1295US10457712B2Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Oct 29, 2019·6 cites·14 claims
- 1395US10221225B2Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Mar 5, 2019·6 cites·4 claims
- 1494US10238725B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 26, 2019·7 cites·20 claims
- 1594US10064926B2Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2015·Granted Sep 4, 2018·12 cites·4 claims
- 1693US10238724B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 26, 2019·6 cites·20 claims
- 1792US10398766B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Sep 3, 2019·5 cites·17 claims
- 1892US2024285738A1Novel peptides and combination of peptides for use in immunotherapy against cll and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 1991US11786583B2Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 2091US11260115B1Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Mar 1, 2022·1 cites·20 claims
- 2191US10722566B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jul 28, 2020·1 cites·20 claims
- 2291US10688131B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jun 23, 2020·1 cites·14 claims
- 2391US10335474B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jul 2, 2019·4 cites·20 claims
- 2491US10238726B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 26, 2019·4 cites·20 claims
- 2591US2024408166A1Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2691US2024350602A1Novel peptides & combination of peptides as targets or active ingredients for use in immunotherapy against aml & other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2790US10653761B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted May 19, 2020·1 cites·20 claims
- 2890US10525084B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jan 7, 2020·3 cites·17 claims
- 2990US10335475B2Peptides and combination of peptides for use in immunotherapy against NHL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jul 2, 2019·5 cites·20 claims
- 3090US10117916B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Nov 6, 2018·4 cites·13 claims
- 3190US10064928B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Sep 4, 2018·4 cites·13 claims
- 3289US11083784B2Peptides and combination of peptides for use in immunotherapy against CLL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 10, 2021·1 cites·20 claims
- 3388US10363295B2Peptides and combination of peptides for use in immunotherapy against NHL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jul 30, 2019·4 cites·16 claims
- 3488US10357550B2Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jul 23, 2019·6 cites·15 claims
- 3588US10314898B2Peptides and combination of peptides for use in immunotherapy against NHL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jun 11, 2019·4 cites·19 claims
- 3688US10195232B1Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Feb 5, 2019·2 cites·12 claims
- 3787US12275775B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Apr 15, 2025·0 cites·18 claims
- 3887US12275776B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Apr 15, 2025·0 cites·19 claims
- 3987US10722536B1Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 28, 2020·1 cites·21 claims
- 4087US10668100B1Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jun 2, 2020·1 cites·20 claims
- 4187US10293036B2Peptides and combination of peptides for use in immunotherapy against NHL and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted May 21, 2019·4 cites·17 claims
- 4286US12036271B2Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 4385US11779638B2Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Oct 10, 2023·0 cites·20 claims
- 4484US11559573B2Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 24, 2023·0 cites·20 claims
- 4584US10596196B2Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 24, 2020·1 cites·20 claims
- 4684US10272114B1Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Apr 30, 2019·1 cites·17 claims
- 4784US10238691B1Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 26, 2019·1 cites·15 claims
- 4884US2023203114A1Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 4984US2023212244A1Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 5084US2022226450A1Novel peptides and combination of peptides for use in immunotherapy against cll and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anita Wiebe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →